A long way to go in scar research-further enhancement of basic and clinical research of the scar.
- Author:
Da-hai HU
1
;
Jia-qi LIU
Author Information
1. Department of Burns and Cutaneous Surgery, the Fourth Military Medical University, Xi'an, China.
- Publication Type:Journal Article
- MeSH:
Burns;
pathology;
Cicatrix;
genetics;
pathology;
therapy;
Fibroblasts;
cytology;
Humans;
Keratinocytes;
cytology
- From:
Chinese Journal of Burns
2011;27(6):407-410
- CountryChina
- Language:Chinese
-
Abstract:
Scar, either hypertrophic scar or keloid, is one of the most common complications due to proliferative disorder of fibrosis in the process of wound healing after burn injuries, trauma, and surgical operations. To repair the cosmetic and functional impairments caused by scars poses a great challenge to all the burn surgery workers. With the advances in both basic research and clinical treatment, the understanding of scar formation and the therapeutic strategies of scar have been improved significantly. However, the remaining problems are still outstanding. In this discussion, the advances and problems in the scientific research in this field, including genetic predisposition, candidate gene, dysfunction of fibroblasts, interaction between fibroblasts and keratinocytes, as well as animal models for hypertrophic scar and keloid were summarized. In addition, the progresses in the clinical therapies are also discussed, including pressure treatment, silicone gel sheeting, corticosteroids, laser, and other emerging treatment strategies. The understanding and treatment of scar will improve in the future with further deepening basic research and clinical trials with stricter standard of assessment.
